BHVN
Price
$14.99
Change
+$1.17 (+8.47%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.46B
53 days until earnings call
PTCT
Price
$58.97
Change
+$1.13 (+1.95%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
4.59B
27 days until earnings call
Interact to see
Advertisement

BHVN vs PTCT

Header iconBHVN vs PTCT Comparison
Open Charts BHVN vs PTCTBanner chart's image
Biohaven
Price$14.99
Change+$1.17 (+8.47%)
Volume$53.32K
Capitalization1.46B
PTC Therapeutics
Price$58.97
Change+$1.13 (+1.95%)
Volume$34.56K
Capitalization4.59B
BHVN vs PTCT Comparison Chart in %
Loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHVN vs. PTCT commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a StrongBuy and PTCT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (BHVN: $13.82 vs. PTCT: $57.84)
Brand notoriety: BHVN and PTCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 99% vs. PTCT: 76%
Market capitalization -- BHVN: $1.46B vs. PTCT: $4.59B
BHVN [@Biotechnology] is valued at $1.46B. PTCT’s [@Biotechnology] market capitalization is $4.59B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whilePTCT’s FA Score has 1 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • PTCT’s FA Score: 1 green, 4 red.
According to our system of comparison, PTCT is a better buy in the long-term than BHVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 3 TA indicator(s) are bullish while PTCT’s TA Score has 4 bullish TA indicator(s).

  • BHVN’s TA Score: 3 bullish, 5 bearish.
  • PTCT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both BHVN and PTCT are a bad buy in the short-term.

Price Growth

BHVN (@Biotechnology) experienced а -10.95% price change this week, while PTCT (@Biotechnology) price change was -8.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +9.50%, and the average quarterly price growth was +52.01%.

Reported Earning Dates

BHVN is expected to report earnings on Nov 18, 2025.

PTCT is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCT($4.6B) has a higher market cap than BHVN($1.46B). PTCT YTD gains are higher at: 28.135 vs. BHVN (-62.999). PTCT has higher annual earnings (EBITDA): 841M vs. BHVN (-792.68M). PTCT has more cash in the bank: 1.99B vs. BHVN (405M). BHVN has less debt than PTCT: BHVN (292M) vs PTCT (388M). PTCT has higher revenues than BHVN: PTCT (1.77B) vs BHVN (0).
BHVNPTCTBHVN / PTCT
Capitalization1.46B4.6B32%
EBITDA-792.68M841M-94%
Gain YTD-62.99928.135-224%
P/E RatioN/A8.20-
Revenue01.77B-
Total Cash405M1.99B20%
Total Debt292M388M75%
FUNDAMENTALS RATINGS
BHVN vs PTCT: Fundamental Ratings
BHVN
PTCT
OUTLOOK RATING
1..100
6280
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
10084
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9041
P/E GROWTH RATING
1..100
10015
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHVN's Valuation (61) in the Pharmaceuticals Major industry is somewhat better than the same rating for PTCT (100) in the Biotechnology industry. This means that BHVN’s stock grew somewhat faster than PTCT’s over the last 12 months.

PTCT's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as BHVN (100) in the Pharmaceuticals Major industry. This means that PTCT’s stock grew similarly to BHVN’s over the last 12 months.

PTCT's SMR Rating (100) in the Biotechnology industry is in the same range as BHVN (100) in the Pharmaceuticals Major industry. This means that PTCT’s stock grew similarly to BHVN’s over the last 12 months.

PTCT's Price Growth Rating (41) in the Biotechnology industry is somewhat better than the same rating for BHVN (90) in the Pharmaceuticals Major industry. This means that PTCT’s stock grew somewhat faster than BHVN’s over the last 12 months.

PTCT's P/E Growth Rating (15) in the Biotechnology industry is significantly better than the same rating for BHVN (100) in the Pharmaceuticals Major industry. This means that PTCT’s stock grew significantly faster than BHVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHVNPTCT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GATMX15.97N/A
N/A
Goldman Sachs International T/M Eq A
FSMDX36.95N/A
N/A
Fidelity Mid Cap Index
AFOZX21.11N/A
N/A
Alger Mid Cap Focus Z
SEKAX22.27N/A
N/A
DWS Emerging Markets Equity A
JVTSX79.93N/A
N/A
Janus Henderson Venture S

PTCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with ACLX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCT
1D Price
Change %
PTCT100%
-2.79%
ACLX - PTCT
49%
Loosely correlated
-0.44%
SYRE - PTCT
43%
Loosely correlated
-8.18%
BHVN - PTCT
42%
Loosely correlated
+0.58%
CGON - PTCT
41%
Loosely correlated
-0.55%
XNCR - PTCT
40%
Loosely correlated
-1.34%
More